• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1991年至2005年澳大利亚和新西兰使用符合扩大标准的供体肾脏进行移植的结果。

Outcomes of transplantation using kidneys from donors meeting expanded criteria in Australia and New Zealand, 1991 to 2005.

作者信息

Collins Michael G, Chang Sean H, Russ Graeme R, McDonald Stephen P

机构信息

Nephrology and Transplantation Services, Queen Elizabeth Hospital, Adelaide, Australia.

出版信息

Transplantation. 2009 Apr 27;87(8):1201-9. doi: 10.1097/TP.0b013e31819ec3a6.

DOI:10.1097/TP.0b013e31819ec3a6
PMID:19384167
Abstract

BACKGROUND

Kidneys from expanded criteria donors (ECD) are reported to have inferior transplant outcomes.

METHODS

Using the Australia and New Zealand Dialysis and Transplant Registry, we reviewed deceased donor kidneys transplanted from 1991 to 2005 in Australia and New Zealand, followed until December 2006. ECD was defined using United Network for Organ Sharing criteria. Graft and patient outcomes, estimated glomerular filtration rates (eGFR), acute rejection, and delayed graft function were analyzed by donor-age and ECD status, with adjustment for important covariates.

RESULTS

There were 3248 recipients of non-ECD kidneys and 781 recipients of ECD kidneys. Compared with donors aged less than 50 years, adjusted hazard ratios for graft failure (GF) at 0 to 1 and 1 to 5 years for ECD kidneys from donors aged 60 years or above were 1.92 (1.48-2.49; P<0.001) and 2.52 (1.97-3.23; P<0.001). The hazard ratios for GF were 1.87 (1.31-2.70; P<0.05) for ECD kidneys from donors aged 50 to 59 years in the first year but were not increased subsequently. Mean eGFR at 1 year decreased with increasing donor age and ECD status (56.4 [53.8-58.9] mL/min for kidneys from donors aged <50, 46.6 [45.0-48.3] and 43.5 [41.1-45.9] for non-ECD and ECD donors aged 50 to 59 years, respectively, and 38.6 [36.9-40.4] for donors > or =60; P<0.001) but subsequent eGFR loss was similar except for donors aged 60 years or above (P=0.021). Acute rejection and delayed graft function were more frequent in ECD kidney recipients, but the associations between GF and donor age/ECD status were independent of these factors.

CONCLUSIONS

For recipients of ECD kidneys, donor age 60 years or above is the most significant determinant of poor outcome; donor age 50 to 59 years represents a category of intermediate risk.

摘要

背景

据报道,扩大标准供体(ECD)的肾脏移植效果较差。

方法

利用澳大利亚和新西兰透析与移植登记处的数据,我们回顾了1991年至2005年在澳大利亚和新西兰接受移植的已故供体肾脏,随访至2006年12月。ECD根据器官共享联合网络的标准定义。通过供体年龄和ECD状态分析移植肾和患者的结局、估计肾小球滤过率(eGFR)、急性排斥反应和移植肾功能延迟恢复情况,并对重要的协变量进行调整。

结果

非ECD肾脏受者有3248例,ECD肾脏受者有781例。与年龄小于50岁的供体相比,60岁及以上供体的ECD肾脏在0至1年和1至5年时移植肾失功(GF)的校正风险比分别为1.92(1.48 - 2.49;P<0.001)和2.52(1.97 - 3.23;P<0.001)。50至59岁供体的ECD肾脏在第一年的GF风险比为1.87(1.31 - 2.70;P<0.05),但随后未增加。1年时的平均eGFR随着供体年龄和ECD状态的增加而降低(年龄<50岁供体的肾脏为56.4[53.8 - 58.9]mL/min,50至59岁非ECD和ECD供体的肾脏分别为46.6[45.0 - 48.3]和43.5[41.1 - 45.9],年龄≥60岁供体的肾脏为38.6[36.9 - 40.4];P<0.001),但除60岁及以上供体外,随后的eGFR下降相似(P = 0.021)。急性排斥反应和移植肾功能延迟恢复在ECD肾脏受者中更常见,但GF与供体年龄/ECD状态之间的关联独立于这些因素。

结论

对于ECD肾脏受者,60岁及以上供体是预后不良的最主要决定因素;50至59岁供体代表中等风险类别。

相似文献

1
Outcomes of transplantation using kidneys from donors meeting expanded criteria in Australia and New Zealand, 1991 to 2005.1991年至2005年澳大利亚和新西兰使用符合扩大标准的供体肾脏进行移植的结果。
Transplantation. 2009 Apr 27;87(8):1201-9. doi: 10.1097/TP.0b013e31819ec3a6.
2
Pediatric en bloc kidney transplantation to adult recipients: more than suboptimal?小儿整块式肾移植给成人受者:不仅仅是次优选择?
Transplantation. 2010 Aug 15;90(3):248-54. doi: 10.1097/TP.0b013e3181e641f8.
3
Patient and graft outcomes from deceased kidney donors age 70 years and older: an analysis of the Organ Procurement Transplant Network/United Network of Organ Sharing database.70岁及以上已故肾脏供体的患者和移植物结局:器官获取与移植网络/器官共享联合网络数据库分析
Transplantation. 2008 Jun 15;85(11):1573-9. doi: 10.1097/TP.0b013e31817059a1.
4
Outcomes of kidney transplantation from older living donors to older recipients.老年活体供者向老年受者进行肾移植的结果。
Am J Kidney Dis. 2008 Sep;52(3):541-52. doi: 10.1053/j.ajkd.2008.05.017. Epub 2008 Jul 24.
5
The UNOS Renal Transplant Registry.美国器官共享联合网络肾脏移植登记处。
Clin Transpl. 2002:1-20.
6
The OPTN/UNOS Renal Transplant Registry.器官获取与移植网络/美国器官共享联合网络肾脏移植登记处
Clin Transpl. 2005:1-16.
7
Assessment of kidneys procured from expanded criteria donors before transplantation.移植前对来自扩大标准供体的肾脏进行评估。
Transplant Proc. 2009 Oct;41(8):2966-9. doi: 10.1016/j.transproceed.2009.08.004.
8
The UNOS renal transplant registry.美国器官共享联合网络肾脏移植登记处。
Clin Transpl. 2001:1-18.
9
Parental donors in live-donor kidney transplantation associated with increased rejection rates and reduced glomerular filtration rates.活体供肾移植中的亲属供体与排斥反应率增加及肾小球滤过率降低相关。
Transplantation. 2007 Oct 27;84(8):972-80. doi: 10.1097/01.tp.0000284987.35214.66.
10
The OPTN/UNOS renal transplant registry.器官获取与移植网络/美国器官共享联合网络肾脏移植登记处
Clin Transpl. 2004:1-16.

引用本文的文献

1
Optimizing the Use of Deceased Donor Kidneys at Risk of Discard: A Clinical Practice Guideline.优化面临废弃风险的已故捐赠者肾脏的使用:临床实践指南。
Transpl Int. 2025 Jun 26;38:14596. doi: 10.3389/ti.2025.14596. eCollection 2025.
2
Porcine anti-human lymphocyte immunoglobulin depletes the lymphocyte population to promote successful kidney transplantation.猪抗人淋巴细胞免疫球蛋白可耗竭淋巴细胞群体,从而促进肾移植成功。
Front Immunol. 2023 Mar 9;14:1124790. doi: 10.3389/fimmu.2023.1124790. eCollection 2023.
3
Baseline Characteristics and Representativeness of Participants in the BEST-Fluids Trial: A Randomized Trial of Balanced Crystalloid Solution Versus Saline in Deceased Donor Kidney Transplantation.
BEST-液体试验参与者的基线特征及代表性:一项关于平衡晶体溶液与生理盐水在 deceased 供体肾移植中对比的随机试验
Transplant Direct. 2022 Nov 4;8(12):e1399. doi: 10.1097/TXD.0000000000001399. eCollection 2022 Dec.
4
Long-term outcomes of kidney transplantation from expanded criteria donors with Chinese novel donation policy: donation after citizens' death.中国新型公民逝世后捐献供肾政策下扩展标准供者肾移植的长期结局
BMC Nephrol. 2022 Oct 3;23(1):325. doi: 10.1186/s12882-022-02944-y.
5
Adult Living-Donor Kidney Transplantation, Donor Age, and Donor-Recipient Age.成人活体供肾移植、供者年龄与供受者年龄
Kidney Int Rep. 2021 Oct 14;6(12):3026-3034. doi: 10.1016/j.ekir.2021.10.002. eCollection 2021 Dec.
6
Outcomes with Tacrolimus-Based Immunosuppression After Kidney Transplantation from Standard- and Extended-Criteria Donors - A Post Hoc Analysis of the Prospective OSAKA Study.标准和扩展标准供体肾移植后他克莫司为基础的免疫抑制治疗的结果 - 前瞻性 OSAKA 研究的事后分析。
Ann Transplant. 2020 May 29;25:e920041. doi: 10.12659/AOT.920041.
7
Subclinical Changes in Deceased Donor Kidney Proteomes Are Associated With 12-month Allograft Function Posttransplantation-A Preliminary Study.供体肾蛋白质组学的亚临床变化与移植后 12 个月移植物功能有关——一项初步研究。
Transplantation. 2019 Feb;103(2):323-328. doi: 10.1097/TP.0000000000002358.
8
Strategies for an Expanded Use of Kidneys From Elderly Donors.扩大使用老年供体肾脏的策略。
Transplantation. 2017 Apr;101(4):727-745. doi: 10.1097/TP.0000000000001635.
9
Efficacy and Safety Outcomes of Extended Criteria Donor Kidneys by Subtype: Subgroup Analysis of BENEFIT-EXT at 7 Years After Transplant.按亚型分类的扩大标准供肾的疗效和安全性结果:移植后7年BENEFIT-EXT研究的亚组分析
Am J Transplant. 2017 Jan;17(1):180-190. doi: 10.1111/ajt.13886. Epub 2016 Jul 12.
10
Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study.接受贝拉西普与环孢素治疗的扩大标准供肾受者的长期预后:III期随机研究BENEFIT-EXT的最终结果
Am J Transplant. 2016 Nov;16(11):3192-3201. doi: 10.1111/ajt.13830. Epub 2016 Jun 9.